Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
BLUE ASH, Ohio (WKRC) - An event this weekend in Blue Ash will help support cancer survivors. The Teal Power 5K Run and Walk to Fight Ovarian Cancer is Saturday. Everyone is invited to join hundreds ...